China’s Sinopharm Group won World Health Organization backing for its Covid-19 vaccine, paving the way for a wider rollout of the shot in countries scrambling for immunizations.
The WHO listed the vaccine for emergency use, Director General Tedros Adhanom Ghebreyesus said on Friday. It’s recommended for adults age 18 and over.
WHO’s imprimatur for the state-owned pharmaceutical company’s shot adds another option for Covax, a program supported by WHO and other global health groups that’s aimed at ensuring every country has access to vaccinations. It joins a small supply of immunizations from Pfizer Inc. and its partner BioNTech, AstraZeneca and Johnson & Johnson that are available especially to poor nations that have been shut out as wealthy countries wrapped up most of the existing vaccine supply.
Subscribe to our YouTube channel: [ Ссылка ]
Bloomberg Quicktake brings you live global news and original shows spanning business, technology, politics and culture. Make sense of the stories changing your business and your world.
To watch complete coverage on Bloomberg Quicktake 24/7, visit [ Ссылка ], or watch on Apple TV, Roku, Samsung Smart TV, Fire TV and Android TV on the Bloomberg app.
Have a story to tell? Fill out this survey for a chance to have it featured on Bloomberg Quicktake: [ Ссылка ]
Connect with us on…
YouTube: [ Ссылка ]
Breaking News on YouTube: [ Ссылка ]
Twitter: [ Ссылка ]
Facebook: [ Ссылка ]
Instagram: [ Ссылка ]
